Monday, 18 Nov 2019

TNF inhibitor

Datesort ascending Type Title Save
13 Nov 2019 Social RT @hausmannMD: Holy Molly! TNFi (etanercept, adalimumab, infliximab, or golimumab) completely prevented stokes in patients with DADA2. #AC…
13 Nov 2019 Social RT @Janetbirdope: Infections In out patients are increased as measured by antimicromial scripts with RA and TNFi use comparing popn control…
13 Nov 2019 Social RT @DrKanikaMonga: - Risk of bDMARD withdrawal higher for TNFi monotherapy compared w/ cs/bDMARD combination - If monotherapy necessary, et…
10 Nov 2019 ACR Video Use of TNF Inhibitors: Dr. Olga Petryna
30 Oct 2019 News Psoriasis Risk Increased with TNF Inhibitors in Juveniles
28 Oct 2019 News The Shame Behind Adalimumab Biosimilars
28 Oct 2019 Slide of the day New Biosimilars for Rheumatology - 2019
22 Oct 2019 News Pain Persists Despite TNF Inhibitor Use
22 Oct 2019 News Adalimumab and Pregnancy Outcomes
12 Aug 2019 News Enbrel Patent Battle Won by Amgen
01 Aug 2019 News TNF Inhibitor and Biologic Induced Psoriasis
24 Jul 2019 Slide of the day anti-TNF Biosimilars in USA
09 May 2019 Social Analysis of claims data compared hospitalized infection rates among 11,248 matched pairs of new initiators of abatacept or TNF inhibitors. Serious hosp infections were significantly lower in ABA vs infliximab (HR 0.63; 0.47-0.85), but similar to ETN & ADA
29 Mar 2019 News FDA Approves Cimzia for Non-Radiographic Axial Spondyloarthritis
13 Mar 2019 News Lower TNF Inhibitor Persistence in Spondylitis
22 Feb 2019 News The Risk of Tuberculosis with TNF Inhibitors
11 Feb 2019 ACR Video QD Clinic - Breast Cancer & a TNF Inhibitor
06 Feb 2019 Social The EMAs CHMP has issued a eceived a positive opinion for 2 TNF inhibitor biosimilars: Idacio (adalimumab) and Kromeya (adalimumab). For the treatment of select inflammatory and autoimmune disorders
24 Jan 2019 Social Using FMF-KI knockout mice (high TNF levels) researchers find TNF signaling drives pyrin & inflammasome activation; TNF is a critical modulator of pyrin of pyrin-inflammasomopathies like FMF. This is why TNF inhib sometimes work in inflammasomopathies.
19 Dec 2018 Social Study from the UK BSRBR registry shows 34 cancers & 41 deaths in 709 pts. Risk of CA w/ TNFi was not increased (SIR 0.94; 95% CI 0.65,1.34) (but for 2 fold incr risk of nonmelanoma skin CA) & all-cause mortality rate was increased (SMR 1.56) from CV events